---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-134411"
form_type: "8-K"
ticker: "CVRX"
cik: "0001235912"
company_name: "CVRx, Inc."
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T12:38:41.894753+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CVRx reports Q3 revenue $3.4M (+241% YoY); repays $20M loan

## Summary
- Q3 revenue $3.4M (241% YoY increase); U.S. HF revenue $2.5M vs $140K prior year.
- Net loss $6.1M ($0.30/share) vs $3.2M ($9.56/share) prior year; cash $170.9M.
- Fully repaid $20M Horizon loan on Nov 3, including fees total $21.3M.
- FY2021 guidance: revenue $13.3-13.9M; Q4 revenue expected $3.9-4.5M.
- Filed three PMA Supplement submissions for Barostim platform; FDA approval expected H1 2022.

## SEC filing metadata
- accession: 0001104659-21-134411
- form_type: 8-K
- ticker: CVRX
- cik: 0001235912
- company_name: CVRx, Inc.
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.02, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1235912/000110465921134411/0001104659-21-134411-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1235912/000110465921134411/tm2131665d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-134411
- JSON: https://secwatch.observer/filing/0001104659-21-134411.json
- Plain text: https://secwatch.observer/filing/0001104659-21-134411.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.